Traditional Chinese medicine composition medicament for treating xerophthalmia and preparation method thereof

Abstract

The invention belongs to the technical field of traditional Chinese medicine preparations and particularly relates to a traditional Chinese medicine composition medicament for treating xerophthalmia and a preparation method thereof. The traditional Chinese medicine composition medicament for treating the xerophthalmia is prepared from, by weight, 10-15 parts of butterflybush flowers, 22-38 parts of heartleaf houttuynia herb, 5-10 parts of groundsel, 16-30 parts of semen coicis, 6-12 parts of Chinese mahonia leaves, 5-15 parts of evergreen mucuna stems, 15-30 parts of poria cocos, 6-12 parts of cherokee rose fruits, 8-16 parts of indigowoad leaves, 9-19 parts of licorice, 4-16 parts of peltate yam rhizomes, 13-20 parts of cortex albiziae, 20-40 parts of henon bamboo roots, 24-40 parts of hawthorns, 6-17 parts of water hyacinths and 15-25 parts of carrots. The traditional Chinese medicine composition medicament for treating the xerophthalmia is reasonable in formula, simple in preparation, short in treatment course, remarkable in treating effect, high in cure rate and capable of well curing the xerophthalmia and relieving the pain of patients.

Description

(1) Technical field [0001] The invention belongs to the technical field of traditional Chinese medicine preparations, in particular to a traditional Chinese medicine composition for treating dry eye and a preparation method thereof. (2) Background technology [0002] Dry eye syndrome refers to the general term for various diseases caused by abnormal tear quality or quantity or abnormal dynamics caused by any reason, resulting in decreased tear film stability, accompanied by ocular discomfort and (or) ocular surface tissue lesions, also known as Keratoconjunctival xerosis. Common symptoms include dry eyes, easy fatigue, itchy eyes, foreign body sensation, burning sensation, sticky secretions, fear of wind, photophobia, and sensitivity to external stimuli; sometimes the eyes are too dry, the basic tears are insufficient, and instead stimulate reflex tears In severe cases, the eyes will be red and swollen, congested, keratinized, and the corneal epithelium is broken and there ...

AI Technical Summary

Problems solved by technology

2. Insufficient secretion of oil layer: meibomian gland dysfunction due to eyelid disease

3. Insufficient secretion of mucin layer: lack of vitamin A1, chronic conjunctivitis, chemical burns, etc.

However, the above-mentioned treatment mainly plays a role in relieving and health care, and cannot fundamentally treat dry eye patients.

[0005] At present, Western medicine mainly uses artificial tears, contact lenses, punctal closure, blocked lacrimal canaliculus and parotid gland transplantation to treat dry eye. The surface has the effect of relieving dry eye symptoms. Patients need to use artificial tears for a long time to relieve the symptoms of patients, but the maintenance time is short, and most artificial tears contain preservatives and additives. Long-term use can damage the ocular surface , can not play a therapeutic role and has brought great pain to the patient; in addition, blocking the lacrimal puncta or lacrimal canaliculus can prevent the discharge of tears and improve the quantity and quality of tears, which is the most commonly used non-drug treatment for dry eye disease therapy

In addition, the use of sublingual gland free transplantation to treat severe dry eye disease has become a research focus, but the indications should be carefully selected, the scope of application is small, and the cost of treatment is high, so it cannot be widely promoted. The treatment of dry eye syndrome in traditional Chinese medicine is still at a relatively early stage, most of which can only be achieved through acupuncture or traditional Chinese medicine fumigation, and there are not many in-depth researches on the systematic treatment of dry eye syndrome